Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II

Authors not listed

Senseonics, Inc. · 2016

Dysbiosis Human Randomized controlled trial

Abstract

The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2016). A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II. <em>Senseonics, Inc.</em>. https://clinicaltrials.gov/study/NCT02647905

Vancouver

Anonymous. A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II. Senseonics, Inc.. 2016.

BibTeX

@misc{anon2016AProsp, title = {A Prospective, Multicenter Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor, PRECISE II}, author = {Anonymous}, journal = {Senseonics, Inc.}, year = {2016}, }